Friday, May 05, 2006 7:44:35 AM
RPRX has a value of just under 111 M, with cash about 15 so the enterprise value is 90 some million.
If the investment community is placing an IPO value on quantrx of 300 that makes rprx (gotta get used to typing that now) easily worth 300 because they've got 2 drugs with 3 applications, androxal for testosterone deficiency, and proellex for both endometriosis and uterine fibroids. Each of these applications is easily worth 1B sales.
Stock is worth 40 going into time when they are anticipating results from the PIII and filing of the NDA for androxal, IMO.
One hedge fund I spoke with told me with a straight face thathe could see the company getting bought for $100 in a year......
I'll send you more DD by e-mail
--------------------------------------
silver and gold, silver and gold, E.I.E.I.O.
FEATURED North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • Aug 5, 2024 9:00 AM
Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM